<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">21896895</PMID>
<DateCompleted>
<Year>2011</Year>
<Month>11</Month>
<Day>23</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1945-7197</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>96</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2011</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>The Journal of clinical endocrinology and metabolism</Title>
<ISOAbbreviation>J. Clin. Endocrinol. Metab.</ISOAbbreviation>
</Journal>
<ArticleTitle>Update: Hypogonadotropic hypogonadism in type 2 diabetes and obesity.</ArticleTitle>
<Pagination>
<MedlinePgn>2643-51</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1210/jc.2010-2724</ELocationID>
<Abstract>
<AbstractText>Studies over the last few years have clearly established that at least 25% of men with type 2 diabetes have subnormal free testosterone concentrations in association with inappropriately low LH and FSH concentrations. Another 4% have subnormal testosterone concentrations with elevated LH and FSH concentrations. The Endocrine Society, therefore, now recommends the measurement of testosterone in patients with type 2 diabetes on a routine basis. The subnormal testosterone concentrations are not related to glycosylated hemoglobin or duration of diabetes, but are associated with obesity, very high C-reactive protein concentrations, and mild anemia. In addition, subnormal testosterone concentrations in these men are associated with a two to three times elevated risk of cardiovascular events and death in two early studies. Short-term studies of testosterone therapy in hypogonadal men with type 2 diabetes have demonstrated an increase in insulin sensitivity and a decrease in waist circumference. However, the data on the effect of testosterone replacement on glycemic control and cardiovascular risk factors such as cholesterol and C-reactive protein concentrations are inconsistent. As far as sexual function is concerned, testosterone treatment increases libido but does not improve erectile dysfunction and thus, phosphodiesterase inhibitors may be required. Trials of a longer duration are clearly required to definitively establish the benefits and risks of testosterone replacement in patients with type 2 diabetes and low testosterone.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Dandona</LastName>
<ForeName>Paresh</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Division of Endocrinology, State University of New York at Buffalo and Kaleida Health, Buffalo, New York 14209, USA. pdandona@KaleidaHealth.org</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dhindsa</LastName>
<ForeName>Sandeep</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 DK069805</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 DK075877</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Clin Endocrinol Metab</MedlineTA>
<NlmUniqueID>0375362</NlmUniqueID>
<ISSNLinking>0021-972X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003924">Diabetes Mellitus, Type 2</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007006">Hypogonadism</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009765">Obesity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2011</Year>
<Month>9</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2011</Year>
<Month>9</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2011</Year>
<Month>12</Month>
<Day>13</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">21896895</ArticleId>
<ArticleId IdType="pii">96/9/2643</ArticleId>
<ArticleId IdType="doi">10.1210/jc.2010-2724</ArticleId>
<ArticleId IdType="pmc">PMC3167667</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Am J Epidemiol. 2006 Nov 15;164(10):978-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17023544</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetologia. 2007 Feb;50(2):278-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17180352</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes Care. 2007 Apr;30(4):911-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17392552</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Endocrinol. 2007 May;156(5):595-602</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17468196</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Intern Med. 2007 Jun 25;167(12):1252-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17592098</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes Care. 2007 Jul;30(7):1860-1</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17416787</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Circulation. 2007 Dec 4;116(23):2694-701</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18040028</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Endocrinol Metab. 2008 Jan;93(1):68-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17911176</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Endocrinol Metab. 2008 May;93(5):1834-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18319314</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diab Vasc Dis Res. 2008 Jun;5(2):135-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18537102</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Endocrinol Metab. 2008 Jul;93(7):2686-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18445673</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2008;3(9):e3151</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18773087</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes Care. 2008 Oct;31(10):2013-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18650372</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Mol Med. 2008 Dec;8(8):816-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19075678</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Endocr Pract. 2008 Nov;14(8):1000-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19095599</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Endocrinol (Oxf). 2009 Apr;70(4):547-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18702678</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Epidemiol. 2009;24(6):289-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19263227</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Endocrinol Metab. 2009 Jul;94(7):2353-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19351733</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Endocrinol Metab. 2009 Jul;94(7):2482-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19401373</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Androl. 2009 Sep-Oct;30(5):477-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19342698</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Am Coll Cardiol. 2009 Sep 1;54(10):919-27</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19712802</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2009 Sep 17;361(12):1152-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19657112</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Androl. 2009 Nov-Dec;30(6):726-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19578132</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hum Mol Genet. 2010 Feb 1;19(3):535-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19933169</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Endocrinol Metab. 2010 Feb;95(2):639-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20061435</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Endocrinol Metab. 2010 Apr;95(4):1810-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20173018</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gerontol A Biol Sci Med Sci. 2010 May;65(5):503-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20106959</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes Care. 2010 Jun;33(6):1186-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20200299</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Endocrinol Metab. 2010 Jun;95(6):2560-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20525906</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2010 Jul 8;363(2):109-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20592293</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Cardiol. 2010 Sep 3;143(3):343-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19395096</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Heart. 2010 Nov;96(22):1821-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20959649</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Sex Med. 2011 Jan;8(1):284-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20704642</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Chem Lab Med. 2011 Jan;49(1):99-103</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20961190</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes Care. 2011 Apr;34(4):828-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21386088</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes Care. 2011 Aug;34(8):1854-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21715518</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Obes Relat Metab Disord. 2000 Jun;24 Suppl 2:S56-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10997610</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2000 Sep 22;289(5487):2122-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11000114</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neuroendocrinol. 2001 Mar;13(3):296-301</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11207945</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes Care. 2002 Jan;25(1):55-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11772901</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Endocrinol Metab. 2003 Apr;88(4):1497-502</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12679429</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Endocrinology. 2003 Nov;144(11):4868-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12960020</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Endocrinol. 2003 Dec;149(6):601-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14641004</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Immunol. 2004 Jan;25(1):4-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14698276</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes Care. 2004 May;27(5):1036-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15111517</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 1973 Jul 12;289(2):72-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">4575719</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Med Sci. 1992 Jul;304(1):4-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1642253</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Endocr Rev. 1995 Feb;16(1):87-116</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7758434</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Epidemiol. 1996 May 1;143(9):889-97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8610702</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Endocrinol Metab. 1998 Jul;83(7):2266-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9661593</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer. 1999 Jul 15;86(2):312-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10421267</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Endocrinol Metab. 2004 Nov;89(11):5462-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15531498</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Endocrinol Metab. 2005 Mar;90(3):1502-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15572415</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Impot Res. 2005 May-Jun;17(3):264-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15674401</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Endocrinol Metab. 2005 May;90(5):2636-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15713702</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Bone Miner Res. 2005 Aug;20(8):1334-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16007330</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Circulation. 2005 Jul 19;112(3):332-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16009799</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BJU Int. 2005 Oct;96(6):867-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16153219</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Endocr Res. 2005;31(2):139-48</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16353672</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Endocrinology. 2006 Feb;147(2):816-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16293665</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Impot Res. 2006 Mar-Apr;18(2):190-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16136189</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Bone Miner Res. 2006 Apr;21(4):529-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16598372</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes Care. 2006 May;29(5):1120-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16644650</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Endocrinol. 2006 Jun;154(6):899-906</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16728551</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Endocrinol Metab. 2006 Jun;91(6):1995-2010</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16720669</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell Endocrinol. 2006 Jul 25;254-255:133-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16757107</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Intern Med. 2006 Aug 14-28;166(15):1660-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16908801</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Intern Med. 2006 Sep 25;166(17):1871-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17000944</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes Care. 2006 Oct;29(10):2289-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17003308</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2006 Oct 19;355(16):1647-59</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17050889</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</PubmedArticle>